| Literature DB >> 31879665 |
Abstract
BACKGROUND: Culex pipiens L. (Diptera: Culicidae) is an important vector of several pathogens. This mosquito is widely distributed throughout the world. We aimed to determine the susceptibility levels of Cx. pipiens populations to some synthetic pyrethroid insecticides in Antalya, Turkey.Entities:
Keywords: Antalya; Culex pipiens; Mosquito; Resistance; Synthetic pyrethroid
Year: 2019 PMID: 31879665 PMCID: PMC6928386
Source DB: PubMed Journal: J Arthropod Borne Dis ISSN: 2322-1984 Impact factor: 1.198
Fig. 1.Culex pipiens collection sites in various districts of Antalya Province, Turkey in 2017
Location and global positioning system (GPS) coordinates of Cx. pipiens collection sites
| 1 | Alanya | Çıplaklı | 36º33′39.9″ N 32º02′44.2″ E |
| 2 | Alanya | Süleymanlar | 36º40′42.299″ N 31º59′04.256″ E |
| 3 | Döşemealtı | Ilıca | 37º09′12.868″ N 30º37′54.912″ E |
| 4 | Döşemealtı | Killik | 37º12′51.987″ N 30º39′52.588″ E |
| 5 | Kemer | Tekirova | 36º31′04.634″ N 30º32′18.758″ E |
| 6 | Kumluca | Narenciye | 36º21′59.7″ N 30º17′21.3″ E |
| 7 | Kumluca | Solid waste storage area | 36º25′10.538″ N 30º18′30.969″ E |
| 8 | Manavgat | Çakış | 36º54′46.150″ N 31º09′47.825″ E |
Knock-down (KD) rates, mortality rates, KDT50 and KDT95 values and susceptibility status of Cx. pipiens populations from Antalya, Turkey to four synthetic pyrethroids
| N | 165 | 172 | 190 | 167 | 171 | |
| %KD±SE (after 60min) | 100 | 88.21±5.40 | 80.03±5.09 | 94.27±1.47 | 0 | |
| KDT50±SE (min) | 12.10±0.82 | 26.02±0.82 | 26.85±1.24 | 20.66±0.73 | ||
| KDT95±SE (min) | 27.27±2.32 | 85.36±5.74 | 188.76±27.69 | 69.66±4.25 | ||
| χ2 | 24.4440 | 2.0809 | 1.0577 | 3.1637 | ||
| P-level | 0.0065 | 0.9957 | 0.9998 | 0.9773 | ||
| %Mortality±SE (after 24h) | 100 | 91.54± 2.51 | 80.30±3.01 | 93.10±2.08 | 0.63±0.63 | |
| Susceptibility status | S | PR | R | PR | ||
| N | 115 | 112 | 131 | 121 | 102 | |
| %KD±SE (after 60min) | 100 | 94.34±2.67 | 92.96±4.32 | 100 | 0 | |
| KDT50±SE (min) | 11.81±0.68 | 27.61±1.43 | 22.89±0.82 | 14.79±0.48 | ||
| KDT95±SE (min) | 29.59±2.04 | 81.18±9.09 | 86.54±6.32 | 33.66±1.39 | ||
| χ2 | 12.6888 | 17.5235 | 5.6160 | 4.5321 | ||
| P-level | 0.2416 | 0.0636 | 0.8464 | 0.9202 | ||
| %Mortality±SE (after 24h) | 100 | 91.95±3.37 | 90.23±2.45 | 99.19±0.81 | 0.96±0.96 | |
| Susceptibility status | S | PR | PR | S | ||
| N | 118 | 110 | 124 | 138 | 114 | |
| %KD±SE (after 60min) | 100 | 100 | 65.98±7.32 | 100 | 0 | |
| KDT50±SE (min) | 6.00±0.30 | 6.57±0.37 | 47.19±1.41 | 5.57±0.36 | ||
| KDT95±SE (min) | 12.96±0.84 | 17.36±1.06 | 124.14±10.94 | 14.82±1.00 | ||
| χ2 | 0.0344 | 0.0390 | 11.7727 | 0.0646 | ||
| P-level | 0.9999 | 0.9999 | 0.3006 | 0.9999 | ||
| %Mortality±SE (after 24h) | 100 | 100 | 76.51±4.92 | 100 | 5.15±3.16 | |
| Susceptibility status | S | S | R | S | ||
| N | 158 | 154 | 196 | 169 | 144 | |
| %KD±SE (after 60min) | 100 | 98.33±1.67 | 99.58±0.42 | 100 | 0 | |
| KDT50±SE (min) | 9.89±0.41 | 15.85±0.58 | 13.09±0.55 | 12.03±0.46 | ||
| KDT95±SE (min) | 24.78±1.23 | 46.07±2.25 | 40.83±2.10 | 30.61±1.41 | ||
| χ2 | 4.7670 | 4.6889 | 1.7015 | 0.8662 | ||
| P-level | 0.9062 | 0.9110 | 0.9982 | 0.9999 | ||
| %Mortality±SE (after 24h) | 100 | 99.17±0.83 | 97.56±0.86 | 100 | 0 | |
| Susceptibility status | S | S | PR | S | ||
| N | 118 | 121 | 139 | 115 | 109 | |
| %KD±SE (after 60min) | 100 | 100 | 92.00±8.00 | 100 | 0 | |
| KDT50±SE (min) | 6.37±0.35 | 8.96±0.44 | 11.26±0.70 | 12.01±0.50 | ||
| KDT95±SE (min) | 15.95±1.00 | 25.89±1.39 | 60.06±4.72 | 34.32±1.68 | ||
| χ2 | 0.2756 | 1.1492 | 0.9450 | 1.2361 | ||
| P-level | 0.9999 | 0.9997 | 0.9999 | 0.9995 | ||
| %Mortality±SE (after 24h) | 100 | 100 | 91.70±4.39 | 100 | 1.71±1.05 | |
| Susceptibility status | S | S | PR | S | ||
| N | 149 | 147 | 171 | 155 | 148 | |
| %KD±SE (after 60min) | 100 | 99.28±0.72 | 93.10±3.01 | 96.14±1.76 | 0 | |
| KDT50±SE (min) | 11.35±0.43 | 16.84±0.75 | 19.69±0.70 | 14.67±0.58 | ||
| KDT95±SE (min) | 26.91±1.24 | 41.77±2.47 | 65.40±3.85 | 45.94±2.37 | ||
| χ2 | 5.8699 | 11.9181 | 1.8928 | 2.4029 | ||
| P-level | 0.8261 | 0.2906 | 0.9971 | 0.9922 | ||
| %Mortality±SE (after 24h) | 100 | 98.55±1.45 | 90.07±2.86 | 96.94±1.08 | 0 | |
| Susceptibility status | S | S | PR | PR | ||
| N | 137 | 134 | 138 | 115 | 138 | |
| %KD±SE (after 60min) | 100 | 100 | 31.31±2.52 | 100 | 0 | |
| KDT50±SE (min) | 8.99±0.34 | 11.93±0.72 | 122.53±20.66 | 9.88±0.37 | ||
| KDT95±SE (min) | 18.51±0.92 | 20.67±1.78 | 744.30±310.93 | 20.81±0.99 | ||
| χ2 | 2.3809 | 32.7119 | 2.9895 | 0.7357 | ||
| P-level | 0.9925 | 0.0003 | 0.9817 | 0.9999 | ||
| %Mortality±SE (after 24h) | 100 | 100 | 58.78±5.34 | 100 | 2.48±1.78 | |
| Susceptibility status | S | S | R | S | ||
| N | 137 | 120 | 133 | 114 | 119 | |
| %KD±SE (after 60min) | 100 | 100 | 84.38±4.61 | 100 | 0 | |
| KDT50±SE (min) | 8.96±0.39 | 12.40±0.48 | 24.82±0.87 | 13.85±0.47 | ||
| KDT95±SE (min) | 21.94±1.13 | 32.58±1.52 | 95.55±7.47 | 32.08±1.36 | ||
| χ2 | 0.0921 | 1.8646 | 4.6029 | 7.4133 | ||
| P-level | 0.9999 | 0.9973 | 0.9161 | 0.6859 | ||
| %Mortality±SE (after 24h) | 100 | 100 | 80.67±5.76 | 100 | 7.93±4.78 | |
| Susceptibility status | S | S | R | S |
N: Number of individuals tested, PR: Possible Resistant, R: Resistant, S: Susceptible, SE: Standard Error
Fig. 2.Mortality rates of Cx. pipiens populations to diagnostic concentrations of synthetic pyrethroids